The results showed that, consistent with our gene chip result, TIPE1 preferentially inhibited the ERK phosphorylation (p-ERK), but not p-p65, p-mTOR, p-S6, or p-MEK, in breast cancer cells (Figure 3C). This evidence concerns the gene MAP2K7 and breast carcinoma.